TCM
Tekla Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $12.3M | Hold |
147,677
| – | – | 0.48% | 51 |
|
|
2023
Q1 | $11.3M | Hold |
147,677
| – | – | 0.43% | 52 |
|
|
2022
Q4 | $12.3M | Hold |
147,677
| – | – | 0.46% | 52 |
|
|
2022
Q3 | $11.7M | Sell |
147,677
-61,477
| -29% | -$4.88M | 0.48% | 50 |
|
|
2022
Q2 | $15.5M | Buy |
209,154
+113,505
| +119% | +$8.43M | 0.61% | 43 |
|
|
2022
Q1 | $8.6M | Buy |
+95,649
| New | +$8.6M | 0.3% | 70 |
|
|
2020
Q1 | – | Sell |
-68,037
| Closed | -$6.47M | – | 222 |
|
|
2019
Q4 | $6.47M | Sell |
68,037
-20,985
| -24% | -$2M | 0.24% | 88 |
|
|
2019
Q3 | $6.79M | Hold |
89,022
| – | – | 0.3% | 66 |
|
|
2019
Q2 | $7.81M | Hold |
89,022
| – | – | 0.32% | 69 |
|
|
2019
Q1 | $8.06M | Sell |
89,022
-55,402
| -38% | -$5.02M | 0.33% | 65 |
|
|
2018
Q4 | $10.4M | Buy |
144,424
+15,424
| +12% | +$1.11M | 0.44% | 45 |
|
|
2018
Q3 | $12.4M | Sell |
129,000
-121,460
| -48% | -$11.6M | 0.45% | 52 |
|
|
2018
Q2 | $23.8M | Hold |
250,460
| – | – | 0.9% | 29 |
|
|
2018
Q1 | $22M | Buy |
250,460
+24,000
| +11% | +$2.11M | 0.85% | 30 |
|
|
2017
Q4 | $19.2M | Hold |
226,460
| – | – | 0.74% | 33 |
|
|
2017
Q3 | $19.6M | Hold |
226,460
| – | – | 0.7% | 33 |
|
|
2017
Q2 | $17.5M | Hold |
226,460
| – | – | 0.65% | 34 |
|
|
2017
Q1 | $15.7M | Buy |
226,460
+47,460
| +27% | +$3.29M | 0.61% | 33 |
|
|
2016
Q4 | $10.6M | Buy |
+179,000
| New | +$10.6M | 0.45% | 51 |
|
|
2016
Q3 | – | Sell |
-294,000
| Closed | -$15.9M | – | 144 |
|
|
2016
Q2 | $15.9M | Hold |
294,000
| – | – | 0.65% | 35 |
|
|
2016
Q1 | $15.2M | Buy |
+294,000
| New | +$15.2M | 0.65% | 35 |
|